However, mutations in various genes related to TKs were detected in the tumor samples (JAK3, NRAS, NTRK2, NF1, SETD2) suggesting frequent alteration of TK pathways for neuroendocrine neoplasms. This evidence concerns the gene SETD2 and neoplasm.